Literature DB >> 7918267

Long-term results of pars plana vitrectomy in the management of complicated uveitis.

A Heiligenhaus1, N Bornfeld, M H Foerster, A Wessing.   

Abstract

This retrospective study evaluates the long term efficacy of pars plana vitrectomy on the preservation of vision in complicated chronic uveitis, including endogenous intermediate uveitis and other entities. Combined vitrectomy-lensectomy was performed in 10 eyes with complicated cataracts, and 18 vitrectomies were done without lensectomies. The mean follow up was 45 months. Additional retinal surgery (for example, scleral buckling) was performed in five eyes. Visual acuity improved in 23 eyes (82.8%) following surgery, with 16 eyes (57%) achieving a vision better than 6/24. The main causes for vision less than 6/24 were persistent cystoid macular oedema (three eyes), macular puckers (one eye), retinal vascular obliterations (four eyes), optic atrophy (five eyes), and chorioretinal scars (seven eyes). Postoperative complications were cataract formation (seven eyes), cystoid macular oedema (one eye), and tractional retinal detachments (three eyes). The surgical intervention resulted in a remarkable reduction of the severity of inflammation or frequency of exacerbations, and allowed significant tapering (11 eyes) or withdrawal (11 eyes) of the topical steroids, or oral corticosteroids (10 cases). Pre-existent cystoid macular oedema resolved in three eyes. Pars plana vitrectomy, eventually combined with lensectomy, may visually rehabilitate eyes with chronic uveitis and media opacities, and may reduce the activity of disease postoperatively.

Entities:  

Mesh:

Year:  1994        PMID: 7918267      PMCID: PMC504862          DOI: 10.1136/bjo.78.7.549

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

Review 1.  Surgical approaches to uveitis.

Authors:  R Belfort; R B Nussenblatt
Journal:  Int Ophthalmol Clin       Date:  1990

2.  [Value of vitrectomy in intermediate uveitis and Behçet's disease with hyalitis. A study of 400 cases].

Authors:  S Limon; J Renard; G Waligora; M Mokrane
Journal:  Ophtalmologie       Date:  1989 Jun-Aug

3.  Surgical management of vitreomacular traction syndromes.

Authors:  R R Margherio; M T Trese; A R Margherio; K Cartright
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

4.  [Pars plana vitrectomy in chronic uveitis].

Authors:  R Klöti
Journal:  Klin Monbl Augenheilkd       Date:  1988-05       Impact factor: 0.700

5.  Lens implant surgery in pars planitis.

Authors:  J B Michelson; M H Friedlaender; R A Nozik
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

6.  The influence of vitrectomy and lensectomy on experimental uveitis.

Authors:  C J Brinkman; A J Otto; A Kijlstra; A C Breebaart
Journal:  Curr Eye Res       Date:  1990       Impact factor: 2.424

7.  [Pars plana vitrectomy in chronic uveitis in the child].

Authors:  M Ulbig; A Kampik
Journal:  Klin Monbl Augenheilkd       Date:  1989-01       Impact factor: 0.700

8.  Cataract surgery and intraocular lens implantation in patients with uveitis.

Authors:  C S Foster; L P Fong; G Singh
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

9.  Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis.

Authors:  H W Flynn; J L Davis; W W Culbertson
Journal:  Ophthalmology       Date:  1988-08       Impact factor: 12.079

10.  Vitrectomy in the management of peripheral uveitis.

Authors:  W F Mieler; B R Will; H Lewis; T M Aaberg
Journal:  Ophthalmology       Date:  1988-07       Impact factor: 12.079

View more
  10 in total

Review 1.  The place of vitreoretinal surgery in the treatment of macular oedema.

Authors:  G W Aylward
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

2.  The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.

Authors:  P Tranos; R Scott; H Zambarakji; H Zambarajki; W Ayliffe; C Pavesio; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 3.  [Guidelines nr. 24a intermediate uveitis].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

4.  Causes and frequency of blindness in patients with intraocular inflammatory disease.

Authors:  A Rothova; M S Suttorp-van Schulten; W Frits Treffers; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

5.  Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.

Authors:  Matthias Gutfleisch; Georg Spital; Anne Mingels; Daniel Pauleikhoff; Albrecht Lommatzsch; Arnd Heiligenhaus
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

6.  Macular grid laser photocoagulation in uveitis.

Authors:  M S Suttorp-Schulten; E Feron; F Postema; A Kijlstra; A Rothova
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

7.  Cataract surgery in uveitis.

Authors:  Rupesh Agrawal; Somashiela Murthy; Sudha K Ganesh; Chee Soon Phaik; Virender Sangwan; Jyotimai Biswas
Journal:  Int J Inflam       Date:  2012-02-08

Review 8.  Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.

Authors:  Pinar Cakar Ozdal; Nilufer Berker; Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

9.  The Effectiveness of Pre- and Postoperative Infliximab in Controlling Behçet's Disease Posterior Uveitis in Patients Undergoing Vitrectomy: A Preliminary Study.

Authors:  Hossam El Din Mohamed Khalil; Heba A El Gendy; Hala Ahmed Raafat; Hazem Effat Haroun; Tamer Atef Gheita; Hossam Mahmoud Bakir
Journal:  J Ophthalmol       Date:  2017-04-04       Impact factor: 1.909

10.  Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis.

Authors:  Yong Un Shin; Joo Young Shin; Dae Joong Ma; Heeyoon Cho; Hyeong Gon Yu
Journal:  J Ophthalmol       Date:  2017-03-30       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.